The endogenous cannabinoid system and the basal ganglia
- 14 August 2002
- journal article
- review article
- Published by Elsevier in Pharmacology & Therapeutics
- Vol. 95 (2) , 137-152
- https://doi.org/10.1016/s0163-7258(02)00253-x
Abstract
No abstract availableKeywords
This publication has 149 references indexed in Scilit:
- SR141716A, a potent and selective antagonist of the brain cannabinoid receptorPublished by Wiley ,2001
- Brain Regional Distribution of Endocannabinoids: Implications for Their Biosynthesis and Biological FunctionBiochemical and Biophysical Research Communications, 1999
- Fatty Acid Sulfonyl Fluorides Inhibit Anandamide Metabolism and Bind to the Cannabinoid ReceptorBiochemical and Biophysical Research Communications, 1997
- Extrapyramidal effects of methanandamide, an analog of anandamide, the endogenous CB1, receptor ligandLife Sciences, 1996
- Occurrence and postmortem generation of anandamide and other long‐chain N‐acylethanolamines in mammalian brainFEBS Letters, 1995
- The cannabinoid agonists WIN 55,212-2 and CP 55,940 attenuate rotational behavior induced by a dopamine D1 but not a D2 agonist in rats with unilateral lesions of the nigrostriatal pathwayBrain Research, 1995
- The endogenous cannabinoid receptor ligand, anandamide, inhibits the motor behavior: role of nigrostriatal dopaminergic neuronsLife Sciences, 1995
- Glutamatergic regulation of cannabinoid receptor gene expression in the caudate-putamenEuropean Journal of Pharmacology: Molecular Pharmacology, 1994
- Age-related loss of cannabinoid receptor binding sites and mRNA in the rat striatumNeuroscience Letters, 1992
- Isolation, Structure, and Partial Synthesis of an Active Constituent of HashishJournal of the American Chemical Society, 1964